Want to see IN:GLAXO full AI Analyst Report?
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) Revenue
GlaxoSmithKline Pharmaceuticals Limited Revenue
GlaxoSmithKline Pharmaceuticals Limited had a revenue of 9.38B in the quarter ending Jun 30, 2026, with -5.71%. This bring the company's revenue in the last twelve months to 39.55B, Increased 3.49%. In the fiscal year ending Mar 31, 2026, GlaxoSmithKline Pharmaceuticals Limited had annual revenue of 38.22B with 2.57% growth.
- Revenue (ttm)
- 39.55B
- Revenue Growth
- 5.75%
- P/S Ratio
- 11.01
- Revenue/Employee
- INR 12,316,049
- Employees
- 3,103
- Market Cap
- INR 420.73B
Revenue Chart
GlaxoSmithKline Pharmaceuticals Limited Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 38.22B | 956.35M | 2.57% |
| Mar 31, 2025 | 37.26B | 2.84B | 8.26% |
| Mar 31, 2024 | 34.42B | 2.15B | 6.68% |
| Mar 31, 2023 | 32.26B | -377.02M | -1.16% |
| Mar 31, 2022 | 32.64B | 3.65B | 12.58% |
| Mar 31, 2021 | 28.99B | -3.00B | -9.37% |
| Mar 31, 2020 | 31.99B | 1.00B | 3.24% |
| Mar 31, 2019 | 30.99B | 2.93B | 10.43% |
| Mar 31, 2018 | 28.06B | -1.02B | -3.52% |
| Mar 31, 2017 | 29.08B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| IN:GLAXO | 39.55B |
| IN:ABBOTINDIA | 69.29B |
| IN:CIPLA | 281.71B |
| IN:GLAND | 67.25B |
| IN:PFIZER | 25.70B |
| IN:SANOFICONR | 4.72B |